The investment company Nexttobe AB, with the entrepreneur Bengt Ågerup at the helm, has increased their shareholding in Oasmia Pharmaceutical AB with 3 432 791 shares and now holds 21.6 % of the shares and votes in Oasmia. The company is Oasmia’s second largest owner.
– That Nexttobe increases their shareholding in Oasmia is very positive in our view since it means that they see the potential in our products and demonstrates a large confidence in our company. We see Nexttobe as a long-term partner and they offer considerable support for us in our business, says Julian Aleksov, CEO of Oasmia.